A new study finds four factors that may make it more likely for some people to experience successful weight loss from using ...

Women who take Wegovy to treat obesity have the greatest likelihood of achieving 10% or more weight loss in a ... which comes in a higher dose, is for weight loss while Victoza is for Type 2 diabetes.

People considering weight-loss medications might wonder which one works best, and first-of-its-kind research points to an answer. A new study published in the New England Journal of Medicine ...

Novo Nordisk seeks EMA approval for 7.2 mg Wegovy dose after trials show 21% weight loss in people with obesity and type 2 diabetes.

Fact checked by Jennifer Klump People who use Wegovy for weight management may be at higher risk for hair loss, according to a preprint study. Researchers found that people prescribed semaglutide ...

There’s no question that the wildly popular injectable weight-loss drugs help people drop pounds, lower heart-disease risk, manage obstructive sleep apnea, and more.But as more people use these ...

Women with obesity and diabetes taking weight loss and diabetes drugs Mounjaro and Zepbound for over a year lost more weight than their male counterparts—but also experienced more nausea and ...

People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head-to-head study of the blockbuster medications.

Using a random sample of 16 million patients, researchers found that women who newly initiated semaglutide (Ozempic, Wegovy) had a twofold higher risk of hair loss than those starting on the ...